Clinical Trial

A Study Comparing Two Mandibular Advancement Devices in the Treatment of Sleep Apnea

Study acronym: MRA OSA
Completed
View on ClinicalTrials.gov →
Summary
The goal of this randomised, controlled cross-over study is to compare two mandibular repositioning devices (MRA) already on the market in the treatment of mild-to-moderate obstructive sleep apnea. Patiënt will test the first MRA for 3 months, after a wash out period of 2 weeks they will test the second MRA for 3 months. It will be randomised what type of MRA will be tested first and second.
Protocol Amendment History 3 changes
critical Completed without a posted recruiting period 2026-08-12
notable Enrollment reduced: 20 -> 16 participants 2026-08-12
notable Primary completion pushed: 2026-01-31 -> 2026-03-06 2026-08-12
Trial Details
NCT Number NCT06810479
Lead Sponsor Ziekenhuis Oost-Limburg
Conditions Apnea, Obstructive
Enrollment 16 participants
Start Date 2025-03-21
Primary Completion 2026-03-06 (estimated)
Study Completion 2026-03-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-11